Israel’s medicinal cannabis policies are about to change. Here’s how
Israel’s new reforms for medicinal cannabis will remove a lot of the heavy regulations in the sector, making it more accessible and boosting new research.
Israel’s new reforms for medicinal cannabis will remove a lot of the heavy regulations in the sector, making it more accessible and boosting new research.
New Zealand’s Medicinal Cannabis Agency has received approval to make a number of changes to the Medicinal Cannabis Scheme. These changes involve amending regulations to better support economic and research opportunities for the medicinal cannabis industry.
Allowing GPs to prescribe medical cannabis can drive down NHS waiting lists and reduce crime, according to a new report from the Cannabis Industry Council (CIC).
Medical cannabis encompasses a wide spectrum of products, including dried flowers, oils, and edibles that contain bioactive compounds such as cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC).
A proposed amendment to the National Defense Authorization Act by Rep. Matt Gaetz (R-Fla.) would end cannabis testing for members of the military — both when they’re enlisting and accepting a commission.
A Guernsey cannabis company says users of medicinal cannabis need a safe space to take the drug.
In a new study titled, “Understanding feeling ‘high’ and its role in medical cannabis patient outcomes,” published in the journal, Frontiers in Pharmacology, researchers at The University of New Mexico, in collaboration with Releaf App, found that patients who reported feeling “high” experienced 7.7% greater symptom relief and an increase in reporting of positive side effects such as “relaxed” and “peaceful.”
Cannabis based medicinal products (CBMPs) have evolved significantly in recent years, marking a paradigm shift in public health attitudes and legislation in the UK.
As cannabis legalization has increased in many countries worldwide, the widespread availability of more potent products, such as concentrates, has also increased. In fact, current estimates indicate that up to 66% of adult cannabis users have reported using concentrates in the past, with up to 37% using these products on a regular basis.
A mother who fought to obtain medicinal cannabis oil for her daughter’s severe epilepsy has said they will lose access to the medication in July.